Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Prosthetic-Joint Infection

about

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Prosthetic-Joint Infection

Item

http://www.wikidata.org/entity/Q58126664

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@en

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@nl

type

Item

label

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@en

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@nl

prefLabel

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@en

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@nl

P1476

Correction of Linezolid-Induce ...... ant Prosthetic-Joint Infection

@en

P2093

Anne Conrad

http://www.w3.org/2001/XMLSchema#string

Christian Chidiac

http://www.w3.org/2001/XMLSchema#string

Claire Triffault-Fillit

http://www.w3.org/2001/XMLSchema#string

Cécile Batailler

http://www.w3.org/2001/XMLSchema#string

Florent Valour

http://www.w3.org/2001/XMLSchema#string

Frédéric Laurent

http://www.w3.org/2001/XMLSchema#string

Tristan Ferry

http://www.w3.org/2001/XMLSchema#string

P2860

Use of pristinamycin for infections by gram-positive bacteria: clinical experience at an Australian hospital.

Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments.

Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.

Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically-relevant Concentrations in cultured Human HL-60 promyelocytes and THP-1 monocytes.

Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients.

Long Term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection.

P304

ofy246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFY246

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30370314

http://www.w3.org/2001/XMLSchema#string

P921

antimicrobial resistance

multiple drug resistance

P932

6198638

http://www.w3.org/2001/XMLSchema#string